Myeloid-specific dopamine D2 receptor signalling controls inflammation in acute pancreatitis via inhibiting M1 macrophage.
Xiao HanJianbo NiZengkai WuJianghong WuBin LiXin YeJuanjuan DaiCongying ChenJing XueRong WanLi WenXingpeng WangGuoyong HuPublished in: British journal of pharmacology (2020)
Our data for the first time showed that myeloid-specific D2 receptor signalling controls pancreatic injury and systemic inflammation via inhibiting M1 macrophage, suggesting D2 receptor activation might serve as therapeutic target for AP.